0.9469
price down icon6.25%   -0.0631
after-market Dopo l'orario di chiusura: .68 -0.2669 -28.19%
loading

Tenaya Therapeutics Inc Borsa (TNYA) Ultime notizie

pulisher
04:25 AM

Tenaya Therapeutics announces securities offering - Investing.com India

04:25 AM
pulisher
04:22 AM

Tenaya Therapeutics Announces Proposed Offering of Common Stock and Warrants - Nasdaq

04:22 AM
pulisher
04:11 AM

Tenaya Therapeutics Announces Proposed Public Offering - GlobeNewswire

04:11 AM
pulisher
04:10 AM

Heart Disease Biotech Tenaya Seeks Fresh Capital Through Complex Warrant Offering - StockTitan

04:10 AM
pulisher
08:27 AM

Tenaya Therapeutics to Participate in Upcoming March Investor Conferences - The Manila Times

08:27 AM
pulisher
08:00 AM

Can Tenaya's Heart Disease Therapies Impress Investors at March Conferences? - StockTitan

08:00 AM
pulisher
Feb 27, 2025

H.C. Wainwright maintains buy rating on Tenaya Therapeutics stock - MSN

Feb 27, 2025
pulisher
Feb 26, 2025

Monitoring Tenaya Therapeutics Inc (TNYA) after recent insider movements - Knox Daily

Feb 26, 2025
pulisher
Feb 22, 2025

Head to Head Survey: Tenaya Therapeutics (NASDAQ:TNYA) and PharmaCyte Biotech (OTCMKTS:PMCBD) - Defense World

Feb 22, 2025
pulisher
Feb 20, 2025

Taking on analysts’ expectations and winning: Tenaya Therapeutics Inc (TNYA) - SETE News

Feb 20, 2025
pulisher
Feb 14, 2025

SG Americas Securities LLC Purchases 15,777 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Feb 14, 2025
pulisher
Feb 12, 2025

It is Poised to be a Bull Market for Tenaya Therapeutics Inc (TNYA) - SETE News

Feb 12, 2025
pulisher
Feb 11, 2025

Technical analysis of Tenaya Therapeutics Inc (TNYA) stock chart patterns - US Post News

Feb 11, 2025
pulisher
Feb 10, 2025

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Feb 10, 2025
pulisher
Feb 10, 2025

Tenaya Therapeutics appoints new interim principal accounting officer - MSN

Feb 10, 2025
pulisher
Feb 10, 2025

Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Target Price at $17.33 - Defense World

Feb 10, 2025
pulisher
Feb 07, 2025

Tenaya Therapeutics appoints new interim principal accounting officer By Investing.com - Investing.com Canada

Feb 07, 2025
pulisher
Feb 07, 2025

Tenaya Therapeutics Appoints Interim Accounting Officer - TipRanks

Feb 07, 2025
pulisher
Feb 07, 2025

Tenaya Therapeutics Inc (TNYA) Stock: A Year of Market Fluctuations - The InvestChronicle

Feb 07, 2025
pulisher
Feb 06, 2025

BlackRock, Inc. Acquires Additional Shares in Tenaya Therapeutics Inc - GuruFocus.com

Feb 06, 2025
pulisher
Feb 06, 2025

A History of Outperforming Analyst Forecasts and Beating the Odds: Tenaya Therapeutics Inc (TNYA) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Tenaya Therapeutics (NASDAQ:TNYA) Earns "Buy" Rating from HC Wainwright - MarketBeat

Feb 06, 2025
pulisher
Feb 05, 2025

Recent Insider Activity Suggests Potential Gains for Tenaya Therapeutics Inc (TNYA) - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Tenaya Therapeutics (NASDAQ:TNYA) Earns “Buy” Rating from HC Wainwright - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Analyze Tenaya Therapeutics Inc (NASDAQ: TNYA) Before Investing. - Stocks Register

Feb 04, 2025
pulisher
Feb 04, 2025

Market Watch Highlights: Tenaya Therapeutics Inc (TNYA) Ends on an Downturn Note at 1.05 - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Is Tenaya Therapeutics Inc (TNYA) a good investment opportunity? - US Post News

Feb 04, 2025
pulisher
Feb 03, 2025

Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine - GlobeNewswire

Feb 03, 2025
pulisher
Feb 03, 2025

TNYATenaya Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Feb 03, 2025
pulisher
Feb 03, 2025

Tenaya Therapeutics receives $8M clinical grant from CIRM - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

Promising Potential of Tenaya Therapeutics: Buy Rating Justified by Financial Backing and Clinical Progress - TipRanks

Feb 03, 2025
pulisher
Feb 03, 2025

Major Funding Breakthrough: Rare Heart Disease Gene Therapy Trial Gets $8M Boost - StockTitan

Feb 03, 2025
pulisher
Jan 29, 2025

Tenaya Therapeutics announces option repricing to retain staff - MSN

Jan 29, 2025
pulisher
Jan 29, 2025

Tenaya Therapeutics announces option repricing to retain staff By Investing.com - Investing.com Australia

Jan 29, 2025
pulisher
Jan 28, 2025

Tenaya Therapeutics Reprices Underwater Stock Options - TipRanks

Jan 28, 2025
pulisher
Jan 23, 2025

Here's Why Tenaya Therapeutics (NASDAQ:TNYA) Must Use Its Cash Wisely - Simply Wall St

Jan 23, 2025
pulisher
Jan 22, 2025

Tenaya Therapeutics (TNYA) Stock Price, News & Analysis - MarketBeat

Jan 22, 2025
pulisher
Jan 16, 2025

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Shares Sold by Jane Street Group LLC - Defense World

Jan 16, 2025
pulisher
Jan 16, 2025

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $17.33 Average PT from Brokerages - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) PT at $17.33 - Defense World

Jan 16, 2025
pulisher
Jan 15, 2025

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Short Interest Update - MarketBeat

Jan 15, 2025
pulisher
Jan 14, 2025

HC Wainwright Reiterates Buy Rating for Tenaya Therapeutics (NASDAQ:TNYA) - MarketBeat

Jan 14, 2025
pulisher
Jan 13, 2025

Tenaya advances gene therapies for heart conditions By Investing.com - Investing.com Canada

Jan 13, 2025
pulisher
Jan 13, 2025

Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones - GlobeNewswire

Jan 13, 2025
$310.03
price down icon 3.13%
$19.13
price down icon 7.54%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Capitalizzazione:     |  Volume (24 ore):